Kristen A. Rahn

418 total citations
9 papers, 350 citations indexed

About

Kristen A. Rahn is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kristen A. Rahn has authored 9 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Kristen A. Rahn's work include Neuropeptides and Animal Physiology (4 papers), Multiple Sclerosis Research Studies (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Kristen A. Rahn is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Multiple Sclerosis Research Studies (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Kristen A. Rahn collaborates with scholars based in United States and Japan. Kristen A. Rahn's co-authors include Patricia J. McLaughlin, Ian S. Zagon, Adam Kaplin, Barbara S. Slusher, Anthony P. Turel, Robert H. Bonneau, Jamie Baum, Manabu Nakamura, Donald K. Layman and Gregory G. Freund and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Journal of Nutrition.

In The Last Decade

Kristen A. Rahn

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristen A. Rahn United States 8 133 109 62 59 59 9 350
Johann Penzien Germany 14 106 0.8× 268 2.5× 96 1.5× 76 1.3× 42 0.7× 17 627
Sandra Vilotti Italy 13 103 0.8× 264 2.4× 34 0.5× 101 1.7× 90 1.5× 17 508
Jean Philippe Breittmayer France 15 80 0.6× 228 2.1× 21 0.3× 154 2.6× 45 0.8× 26 518
Eishi Hara Japan 10 123 0.9× 362 3.3× 50 0.8× 61 1.0× 41 0.7× 13 482
Sara Ståhl Sweden 9 49 0.4× 131 1.2× 34 0.5× 67 1.1× 36 0.6× 10 404
J. Ham United Kingdom 14 96 0.7× 175 1.6× 74 1.2× 58 1.0× 14 0.2× 27 516
Nicole A. Jackman United States 7 113 0.8× 145 1.3× 25 0.4× 55 0.9× 14 0.2× 8 349
Lauren J. Murphree United States 9 160 1.2× 237 2.2× 14 0.2× 99 1.7× 69 1.2× 11 554
Bogdan Popescu Romania 11 61 0.5× 132 1.2× 40 0.6× 58 1.0× 12 0.2× 34 384
Jia Zou China 12 81 0.6× 168 1.5× 11 0.2× 100 1.7× 40 0.7× 19 412

Countries citing papers authored by Kristen A. Rahn

Since Specialization
Citations

This map shows the geographic impact of Kristen A. Rahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen A. Rahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen A. Rahn more than expected).

Fields of papers citing papers by Kristen A. Rahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen A. Rahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen A. Rahn. The network helps show where Kristen A. Rahn may publish in the future.

Co-authorship network of co-authors of Kristen A. Rahn

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen A. Rahn. A scholar is included among the top collaborators of Kristen A. Rahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen A. Rahn. Kristen A. Rahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rahn, Kristen A., Barbara S. Slusher, & Adam Kaplin. (2012). Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition. Current Medicinal Chemistry. 19(9). 1335–1345. 54 indexed citations
2.
Rahn, Kristen A., Crystal C. Watkins, Jesse Alt, et al.. (2012). Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences. 109(49). 20101–20106. 59 indexed citations
3.
Rahn, Kristen A., Barbara S. Slusher, & Adam Kaplin. (2012). Cognitive impairment in multiple sclerosis: a forgotten disability remembered.. PubMed. 2012. 14–14. 39 indexed citations
5.
Zagon, Ian S., Kristen A. Rahn, Robert H. Bonneau, Anthony P. Turel, & Patricia J. McLaughlin. (2009). Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis. Brain Research. 1310. 154–161. 31 indexed citations
6.
Zagon, Ian S., Kristen A. Rahn, Anthony P. Turel, & Patricia J. McLaughlin. (2009). Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis. Experimental Biology and Medicine. 234(11). 1383–1392. 37 indexed citations
7.
Zagon, Ian S., Kristen A. Rahn, & Patricia J. McLaughlin. (2007). Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells. Neuropeptides. 41(6). 441–452. 50 indexed citations
8.
Baum, Jamie, et al.. (2006). A Reduced Carbohydrate, Increased Protein Diet Stabilizes Glycemic Control and Minimizes Adipose Tissue Glucose Disposal in Rats. Journal of Nutrition. 136(7). 1855–1861. 34 indexed citations
9.
Hendricks, Bryan, et al.. (1998). A comparison of Caucasian and Southeast Asian Hmong uterine fundal height during pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 77(5). 521–526. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026